P
PRAXIS PRECISION MEDICINES INC
NASDAQ: PRAX (Praxis Precision Medicines, Inc)
最近更新时间: 20小时之前40.24
2.18 (5.73%)
| 前收盘价格 | 38.06 |
| 收盘价格 | 38.76 |
| 成交量 | 511,850 |
| 平均成交量 (3个月) | 551,569 |
| 市值 | 811,367,232 |
| 价格/销量 (P/S) | 79.68 |
| 股市价格/股市净资产 (P/B) | 1.72 |
| 52周波幅 | |
| 利润日期 | 2 May 2025 |
| 营业利益率 (TTM) | -856.97% |
| 稀释每股收益 (EPS TTM) | -10.21 |
| 季度收入增长率 (YOY) | 1,349.10% |
| 总债务/股东权益 (D/E MRQ) | 0.31% |
| 流动比率 (MRQ) | 10.77 |
| 营业现金流 (OCF TTM) | -131.76 M |
| 杠杆自由现金流 (LFCF TTM) | -69.94 M |
| 资产报酬率 (ROA TTM) | -43.81% |
| 股东权益报酬率 (ROE TTM) | -70.98% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 混合的 |
| Biotechnology (全球的) | 混合的 | 混合的 | |
| 股票 | Praxis Precision Medicines, Inc | 看涨 | 看跌 |
AIStockmoo 评分
2.3
| 分析师共识 | 4.0 |
| 内部交易活动 | NA |
| 价格波动 | 0.5 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | 2.0 |
| 平均 | 2.25 |
|
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Growth |
| 内部持股比例 | 0.46% |
| 机构持股比例 | 110.91% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Cormorant Asset Management, Lp | 31 Dec 2024 | 1,693,219 |
| Perceptive Advisors Llc | 31 Dec 2024 | 1,329,735 |
| Ra Capital Management, L.P. | 31 Dec 2024 | 761,955 |
| Verition Fund Management Llc | 31 Dec 2024 | 464,508 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 111.00 (Deutsche Bank, 175.85%) | 购买 |
| 中 | 85.00 (111.23%) | |
| 低 | 73.00 (Baird, 81.41%) | 购买 |
| 平均值 | 91.80 (128.13%) | |
| 总计 | 5 购买 | |
| 平均价格@调整类型 | 43.60 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| HC Wainwright & Co. | 01 May 2025 | 105.00 (160.93%) | 购买 | 38.06 |
| 03 Mar 2025 | 105.00 (160.93%) | 购买 | 33.55 | |
| Needham | 08 Apr 2025 | 85.00 (111.23%) | 购买 | 28.60 |
| 03 Mar 2025 | 85.00 (111.23%) | 购买 | 33.55 | |
| Baird | 03 Mar 2025 | 73.00 (81.41%) | 购买 | 33.55 |
| Truist Securities | 03 Mar 2025 | 85.00 (111.23%) | 购买 | 33.55 |
| Deutsche Bank | 11 Feb 2025 | 111.00 (175.84%) | 购买 | 84.24 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合